Moderna Announces First Participants Dosed in Phase 2/3 Study of COVID-19 Vaccine Candidate in Adolescents – PharmiWeb.com
Moderna Announces First Participants Dosed in Phase 2/3 Study of COVID-19 Vaccine Candidate in Adolescents PharmiWeb.comUS FDA advisory panel votes in favor of Pfizer's coronavirus vaccine | World News | WION…